-
Are All DOACs Created Equal for Managing Atrial Fibrillation?
New study: Yes, when it comes to efficacy. For safety, Apixaban (Eliquis) is associated with less GI bleedings, but since the absolute percentage of GI bleedings is 2-3,5%, it may only give a marginal clinical benefit to choose Apixaban over the other DOACs
https://www.jwatch.org/na55472/2022/11/08/are-all-doacs-created-equal-managing-atrial-fibrillation
#dklæger #MedMastodon